Like a puppy chasing its tail, some new investors often chase ‘the next big thing’, even if that means buying ‘story stocks’ without revenue, let alone profit.But as Warren Buffett has mused, ‘If you’ve been playing poker for half an hour and you still don’t know who the patsy is, you’re the patsy.’ When they buy such story stocks, investors are all too often the patsy.
So if you’re like me, you might be more interested in profitable, growing companies, like Generic Sweden ( STO:GENI ).While that doesn’t make the shares worth buying at any price, you can’t deny that successful capitalism requires profit, eventually.While a well funded company may sustain losses for years, unless its owners have an endless appetite for subsidizing the customer, it will need to generate a profit eventually, or else breathe its last breath.
Check out our latest analysis for Generic Sweden How Fast Is Generic Sweden Growing?
If a company can keep growing earnings per share (EPS) long enough, its share price will eventually follow.That means EPS growth is considered a real positive by most successful long-term investors.
Who among us would not applaud Generic Sweden’s stratospheric annual EPS growth of 39%, compound, over the last three years? That sort of growth never lasts long, but like a shooting star it is well worth watching when it happens.
I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company’s growth.Generic Sweden maintained stable EBIT margins over the last year, all while growing revenue 16% to kr70m.That’s a real positive.
In the chart below, you can see how the company has grown earnings, and revenue, over time.Click on the chart to see the exact numbers.OM:GENI Income Statement April 26th 2020
Since Generic Sweden is no giant, with a market capitalization of kr278m, so you should definitely check its cash and debt before getting too excited about its prospects.
Are Generic Sweden Insiders Aligned With All Shareholders?
Many consider high insider ownership to be a strong sign of alignment between the leaders of a company and the ordinary shareholders.So as you can imagine, the fact that Generic Sweden insiders own a significant number of shares certainly appeals to me.
Actually, with 41% of the company to their names, insiders are profoundly invested in the business.I’m reassured by this kind of alignment, as it suggests the business will be run for the benefit of shareholders.
Valued at only kr278m Generic Sweden is really small for a listed company.So despite a large proportional holding, insiders only have kr113m worth of stock.
That’s not a huge stake in absolute terms, but it should help keep insiders aligned with other shareholders.Is Generic Sweden Worth Keeping An Eye On?
Generic Sweden’s earnings have taken off like any random crypto-currency did, back in 2017.That sort of growth is nothing short of eye-catching, and the large investment held by insiders certainly brightens my view of the company.At times fast EPS growth is a sign the business has reached an inflection point; and I do like those.
So yes, on this short analysis I do think it’s worth considering Generic Sweden for a spot on your watchlist.Before you take the next step you should know about the 3 warning signs for Generic Sweden (1 can’t be ignored!) that we have uncovered.
Although Generic Sweden certainly looks good to me, I would like it more if insiders were buying up shares.If you like to see insider buying, too, then this free list of growing companies that insiders are buying , could be exactly what you’re looking for.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
If you spot an error that warrants correction, please contact the editor at .This article by Simply Wall St is general in nature.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data.Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.Thank you for reading.These great dividend stocks are beating your savings account Not only have these stocks been reliable dividend payers for the last 10 years but with the yield over 3% they are also easily beating your savings account (let alone the possible capital gains).Click here to see them for FREE on Simply Wall St .Share this article: Simply Wall St Simply Wall St is a financial technology startup focused on providing unbiased, high-quality research coverage on every listed company in the world.
Our research team consists of equity analysts with a public, market-beating track record.Learn more about the team behind Simply Wall St .GENI’s investment overview GENI’s Competitors About Us Become a better investor Simply Wall St is an award winning start-up aiming to replace human stockbrokers by providing you with high quality financial data and analysis presented in a beautiful visual way everybody can understand, at a fraction of the cost (try our FREE plan).
Simply Wall Street Pty Ltd 24 Kippax St, Sydney ACN 600 056 611 Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs.You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Please read our Financial Services Guide before deciding whether to obtain financial services from us.Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No.337927)..